Morgan Stanley Miromatrix Medical Inc. Transaction History

Morgan Stanley

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Oct 27, 2022	SELL	$3.36 - $4.32 $1,703 - $2,190	-507 Reduced 33.64%	1,000 $4,000
Q2 2022 Aug 15, 2022	SELL	$3.36 - $4.32 $1,703 - $2,190	-507 Reduced 33.64%	1,000 $4,000
Q1 2022 Oct 27, 2022	BUY	$2.03 - $4.73 $1,029 - $2,398	507 Added 50.7%	1,507 $6,000
Q1 2022 May 13, 2022	BUY	$2.03 - $4.73 $3,059 - $7,128	1,507 New	1,507 $6,000

Ticker MIRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,899,200
Description
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified huma...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.